ChemoMetec A/S Overview
Pro stress-test →ChemoMetec is a Danish biotech instrumentation company specializing in automated cell counting and analysis solutions. Founded in 1997 and publicly listed on Nasdaq OMX Copenhagen, the company manufactures advanced analytical instruments used for quantitative analysis of cells in liquids, serving pharmaceutical, biotechnology, and research sectors globally.
Strategic Profile
Pro stress-test →ChemoMetec differentiates through proprietary automation technology that eliminates human error and subjectivity in cell counting—a critical requirement in GMP-regulated pharmaceutical production and cell therapy manufacturing. The company employs a recurring revenue model through both instrument sales and consumables, while strategically expanding capabilities through acquisitions like Ovizio Imaging Systems (October 2024) to add holographic microscopy technology for bioprocessing applications.
Competitive Landscape
Pro stress-test →ChemoMetec operates in the specialized cell analysis instrumentation space competing against larger diversified life sciences equipment manufacturers and niche automation suppliers. Competitors include automated cell counter manufacturers serving pharmaceutical and biotech QC/production, though ChemoMetec's focus on accuracy and regulatory compliance in GMP environments provides differentiation. The market benefits from consolidation trends in cell therapy and bioprocessing automation.
Industry Context
ChemoMetec A/S operates in Life Sciences Instrumentation / Biotech Equipment Manufacturing.
Key facts
Founded: 1997 · Headquarters: Allerød, Denmark · Employees: 51-100